menu
    • menu

    Company profile for Innocan Pharma

    NEW Drugs in Dev: 1
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Innocan Pharma is a pharmaceutical tech company that focuses on the development of several drug delivery platforms combining cannabidiol (“CBD”) with other pharmaceutical ingredients as well as the development and sale of CBD-integrated pharmaceuticals. The Company’s operations and research and development activities are based in Israel. Innocan Pharma’s business can be described as three distinct operating segments r...
    Innocan Pharma is a pharmaceutical tech company that focuses on the development of several drug delivery platforms combining cannabidiol (“CBD”) with other pharmaceutical ingredients as well as the development and sale of CBD-integrated pharmaceuticals. The Company’s operations and research and development activities are based in Israel. Innocan Pharma’s business can be described as three distinct operating segments relating to the incorporation in products of CBD in their formulation: (i) the research and development of the treatment of Covid-19 (and other viruses causing lung inflammation as well as other central nervous system

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Innocan PharmaIsrael Flag
    Country
    Country
    Israel
    Address
    Address
    Dizengoff St 50, Tel Aviv, Tel Aviv 6433
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://innocanpharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    International Sweetener Colloquium

    Not Confirmed

    envelop Contact Supplier

    International Sweetener Colloquium

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Innocan Pharma Shows LPT-CBD Pain Relief In Dogs Study
    Innocan Pharma Shows LPT-CBD Pain Relief In Dogs Study

    09 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/innocan-pharma-announces-lpt-cbd-demonstrates-pain-relief-over-placebo-results-from-a-randomized-blinded-clinical-study-in-dogs-302682620.html

    PR NEWSWIRE
    09 Feb 2026
    Share Share
    Innocan Pharma Eyes NYSE Listing and Offering
    Innocan Pharma Eyes NYSE Listing and Offering

    27 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/innocan-pharma-corporation-anticipates-listing-on-the-nyse-american-stock-exchange-with-concurrent-offering-302671702.html

    PR NEWSWIRE
    27 Jan 2026
    Share Share
    Innocan Pharma Eyes NYSE Listing and Concurrent Offering
    Innocan Pharma Eyes NYSE Listing and Concurrent Offering

    02 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/innocan-pharma-corporation-anticipates-listing-on-the-nyse-american-stock-exchange-with-concurrent-offering-302651674.html

    PR NEWSWIRE
    02 Jan 2026
    Share Share
    Innocan Pharma Files Amended Statement For U.S. Offering
    Innocan Pharma Files Amended Statement For U.S. Offering

    10 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/innocan-pharma-announces-public-filing-of-amended-registration-statement-for-proposed-us-public-offering-302638104.html

    PR NEWSWIRE
    10 Dec 2025
    Share Share
    Innocan Pharma Reveals Q3 2025 Financials: Revenues Reach $21.6M
    Innocan Pharma Reveals Q3 2025 Financials: Revenues Reach $21.6M

    27 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/innocan-pharma-reports-financial-results-for-q3-2025--with-revenues-at-us-21-6m-302627377.html

    PR NEWSWIRE
    27 Nov 2025
    Share Share
    Innocan Reports Strong Pain Relief Data For LPT-CBD In Goats
    Innocan Reports Strong Pain Relief Data For LPT-CBD In Goats

    24 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/innocan-pharma-announces-promising-translational-evidence-from-a-pain-relief-study-of-repeated-lpt-cbd-administration-in-goats-302624903.html

    PR NEWSWIRE
    24 Nov 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search